Microbial Robotics will present at CleanEquity Monaco 2015 on March 5th & 6th at the Oceanographic Museum of Monaco.
CleanEquity Monaco is an annual invitation-only event hosted by Innovator Capital, the London-based boutique investment bank.
Other partners and sponsors include Prince Albert II of Monaco's Foundation, Covington & Burling, The Climate Group, Porter Novelli, Cranfield University, PR Newswire, the Monte-Carlo SBM, Oceanographic Museum of Monaco and the Monaco Chamber of Economic Development.
Microbial Robotics has been identified by an expert panel as one of the world's most innovative cleantech companies and has been selected to present to senior financial and strategic cleantech investors, policy makers, legislators, end users and media.
About Microbial Robotics LLC
A six-year-old global biotechnology firm, Microbial Robotics uses open and proprietary technologies to develop synthetic biology-based, microorganism products. The Company discovers and develops enhanced organisms that include genetically modified bacteria (BactoBots™) and genetically modified viruses (ViruBots™). These organism-based "MicrobialBots™" become platforms to produce, build, sense, and perform functions for the water, energy, chemical, and pharmaceutical industries. When a MicrobialBot technology is developed, the microbial culture, product development plan, and intellectual property are placed into a branded subsidiary. That subsidiary then seeks industry expert partners to lead the product to market. To globally scale, the Company developed a unique, "open" synthetic biology business model. The Company's MicrobialBots are protected against theft and misuse, or accidental release, by a consumable genetics rights management (GeRM™) system. When the MicrobialBots are separated from the commodity priced additive molecular keys, the MicrobialBots cease reproduction and eventually die.
The Company is headquartered in Ohio with laboratory operations in Kentucky and Spain via its strategic partner, Bacmine SL.